Earnings
Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
Hydreight Revenue Guidance Confirmed, But Execution Risk Remains on 4x Growth Target

Executive Summary
- Victory Square Technologies reported Fiscal 2025 audited financial results showing consolidated revenue of $35.4 million, a 121% increase year-over-year from FY2024 ($16.04M).
- Hydreight Technologies Inc., the primary operating subsidiary, contributed significantly to this growth with adjusted EBITDA turning positive at $2.5 million compared to $136K in FY2024.
- The company reiterated forward revenue guidance for Fiscal 2026 of approximately $150 million for Hydreight Technologies, a figure previously disclosed in February 2026.
- Cash and marketable securities increased to $22.0 million with working capital at $15.0 million, indicating improved liquidity compared to prior periods.
- Operational metrics show over 11,000 licenses signed for the VSDHOne healthcare platform and a distribution of Yocale.ai shares completed in April 2026.
- Pawsible Ventures launched a $10M venture fund targeting pet health infrastructure, expanding the company's portfolio beyond digital health.
Material Impact
- The Fiscal 2025 revenue beat ($35.4M vs FY2024 $16.04M) validates the growth trajectory but does not introduce new upside beyond expectations set in February 2026 when the $150M guidance was first issued.
- Profitability improvement (Adjusted EBITDA of $2.5M) is a positive confirmation that Hydreight has reached operational leverage, reducing the risk of immediate capital dilution for operations.
- The reiterated $150M FY2026 guidance represents a 4x increase from current run rates; while confirmed by management, this remains an aggressive target with significant execution risk if partner activity does not scale as projected.
- Since the core catalyst (the $150M guidance) was already public in February and March news releases, this earnings release is largely confirmatory rather than transformative for valuation.
- The stock price has corrected from September highs ($0.98) to current levels ($0.72), suggesting the market may have priced in the growth expectations earlier; this news reinforces the thesis but does not justify a new breakout without further catalysts.
VST · Price
Company Overview
- Company: Victory Square Technologies Inc. (CSE: VST).
- Flagship Project: Hydreight Technologies Inc., a digital health infrastructure platform operating across 50 U.S. states.
- Platform: VSDHOne, a modular compliance framework for telehealth and pharmacy fulfillment supporting GLP-1s, TRT, peptides, and other categories.
- Portfolio: Includes Insu Therapeutics (biotech), Pawsible Ventures (pet health fund), SafeTest Diagnósticos (Brazil diagnostics), and XR Immersive Technologies.
- Business Model: Revenue generated through platform licensing, transaction fees on product orders placed, and venture investments in portfolio companies.
More from Victory Square Technologies Inc.
Jun 02, 2026 · 00:03